搜索临床试验以:依维莫司 (RAD001)
总计1062个结果
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
University Hospital, Basel, Switzerland完全的
-
Novartis Pharmaceuticals完全的
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)招聘中
-
Poitiers University HospitalChiesi Farmaceutici S.p.A.终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
The PCI Guideline Research Society未知
-
University of RegensburgNovartis Pharmaceuticals未知
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer Institute完全的
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals完全的
-
Emory UniversityMedtronic完全的
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...主动,不招人
-
Aarhus University Hospital SkejbyBoston Scientific Corporation; Biosensors Europe SA未知
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical Center招聘中
-
Fondazione Ricerca e Innovazione Cardiovascolare...招聘中
-
The Hospital District of Satakunta未知心肌梗塞 | 动脉粥样硬化 | 经皮冠状动脉介入治疗芬兰
-
Celularity IncorporatedCelgene Corporation终止
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人
-
Spanish Society of Cardiology未知
-
Avera McKennan Hospital & University Health Center主动,不招人
-
Iwate Medical University完全的
-
University Hospital, ToulouseBoston Scientific Corporation完全的
-
University of Kansas Medical CenterGlaxoSmithKline; Novartis未知
-
Northwestern UniversityNovartis Pharmaceuticals完全的
-
Zhejiang DTRM Biopharma招聘中滤泡性淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 难治性慢性淋巴细胞白血病 | 里希特的转变 | 复发性慢性淋巴细胞白血病美国
-
Medtronic VascularMedtronic Bakken Research Center完全的
-
University College, London终止
-
Eisai Inc.Merck Sharp & Dohme LLC主动,不招人肾细胞癌西班牙, 加拿大, 葡萄牙, 大韩民国, 台湾, 美国, 荷兰, 英国, 捷克语, 意大利, 芬兰, 希腊, 罗马尼亚, 澳大利亚, 波兰, 俄罗斯联邦
-
University Hospital, Strasbourg, France主动,不招人